Pharmacological Evaluation of Momordica Charantia for Anti-Inflammatory and Wound Healing Potential

The present study aimed to evaluate the anti-inflammatory effects and wound healing potential of Momordica charantia fruit extracts. Plant material was subjected to maceration and Soxhlet extraction, and the resulting extracts were analyzed for physicochemical parameters including water- and alcohol‑soluble extractive values, as well as acid and water‑soluble ash content. Quantitative phytochemical analysis confirmed the presence of active constituents, with the methanolic extract showing a total phenolic content of 72.22 mg GAE/g and a total flavonoid content of 72.23 mg GAE/g. Pharmacological evaluation was performed using two animal models: carrageenan‑induced paw edema in rats for anti-inflammatory activity, and the incision wound model for wound healing potential. The ethyl acetate extract at 20 mg/kg body weight demonstrated maximum inhibition of inflammation (76.92%), which was comparable to the standard drug indomethacin (10 mg, 82.69%). In wound healing studies, the methanolic extract exhibited superior tensile strength (512.62 ± 1.23 g) compared to EMC (489.60 ± 0.58 g), EAMC (338.63 ± 1.66 g), and the standard formulation. Overall, the findings indicate that Momordica charantia possesses significant anti-inflammatory activity and enhanced wound healing properties, with the methanolic extract showing particularly promising results for potential therapeutic and commercial applications.

Momordica Charantia, anti-inflammatory

1. Liu, J. Q., Chen, J. C., Wang, C. F., Qiu, M. H., Liu, Z., & Gong, J. (2021). New cucurbitane triterpenoids and steroidal glycoside from Momordica charantia: The effect of Momordica charantia in the treatment of diabetes mellitus—A review. Molecules / Evidence-Based Complementary and Alternative Medicine, 14(2), 4804–4813. [Google Scholar] [Crossref]

2. Gupta, R., Vengurlekar, S., Jain, S. K., & Rajoriya, V. (n.d.). Balancing preservation and access. In Quality assurance of ethno-herbals: Cultivating confidence in alternative medicine (pp. 93–112). [Google Scholar] [Crossref]

3. Wang, Q., Wu, X., Shi, F., & Liu, Y. (2019). Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice. Biomedicine & Pharmacotherapy, 109, 744–750. [Google Scholar] [Crossref]

4. Bhat, G. A., Khan, H. A., Alhomida, A. S., Sharma, S., Singh, R., & Paray, B. A. (2018). GLP-1 secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia. BMC Complementary and Alternative Medicine, 18(1), 365–372. [Google Scholar] [Crossref]

5. Cortez-Navarrete, M., Martínez-Abundis, E., Perez-Rubio, K. G., & Gonzalez-Ortiz, M. (2018). Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus. Journal of Medicinal Food, 21(7), 672–677. [Google Scholar] [Crossref]

6. Rajoriya, V., Kashaw, V., & Kashaw, S. K. (2021). Folate conjugated solid lipid nanoparticle: Formulation development, optimization, and characterization. Current Nanomedicine, 11(3), 186–199. [Google Scholar] [Crossref]

7. Mahmoud, M. F., El-Ashry, F. E., El Maraghy, N. N., & Fahmy, A. (2017). Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats. Pharmaceutical Biology, 55(1), 758–765. [Google Scholar] [Crossref]

8. Ma, C., Yu, H., Xiao, Y., & Wang, H. (2017). Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats. Pharmaceutical Biology, 55(1), 2170–2177. [Google Scholar] [Crossref]

9. Kulkarni, P., Lohidasan, S., & Mahadik, K. (2021). Isolation, characterization and investigation of in vitro antidiabetic and antioxidant activity of phytoconstituents from fruit of Momordica charantia Linn. Natural Product Research, 35(6), 1035–1037. [Google Scholar] [Crossref]

10. Lee, Y. H., Yoon, S. Y., Baek, J., Kim, S. J., Yu, J. S., & Kang, H. (2021). Metabolite profile of cucurbitane-type triterpenoids of bitter melon (Momordica charantia) and their inhibitory activity against protein tyrosine phosphatases relevant to insulin resistance. Journal of Agricultural and Food Chemistry, 69(6), 1816–1830. [Google Scholar] [Crossref]

11. Dwijayanti, D. R., Shimada, T., & Ishii, T. (2020). Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in mice. Phytotherapy Research, 34(6), 1338–1346. [Google Scholar] [Crossref]

12. Ru, Y., Liu, K., Kong, X., Li, X., Shi, X., & Chen, H. (2020). Synthesis of selenylated polysaccharides from Momordica charantia L. and its hypoglycemic activity in streptozotocin-induced diabetic mice. International Journal of Biological Macromolecules, 152, 295–304. [Google Scholar] [Crossref]

13. Park, S. H., Yi, Y. S., Kim, M. Y., & Cho, J. Y. (2019). Antioxidative and anti-melanogenesis effect of Momordica charantia methanol extract. Evidence-Based Complementary and Alternative Medicine, 3(2), 509–520. [Google Scholar] [Crossref]

14. Rajoriya, V., & Gupta, R. (2025). Folate functionalized nanostructured lipid carriers of paclitaxel for site-specific A549 lung adenocarcinoma targeting. BioNanoScience, 15, 503. [Google Scholar] [Crossref]

15. Yaldız, G., Sekeroglu, N., Kulak, M., & Demirkol, G. (2015). Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: A case study for adaptation. Natural Product Research, 29(6), 543–545. [Google Scholar] [Crossref]

16. Shukla, R., & Kashaw, V. (2018). Wound healing prospective of Pongamia glabra, Piper nigrum and Momordica charantia on albino rats using anemic burn wound model. Journal of Drug Delivery & Therapeutics, 8(6-s), 146–154. [Google Scholar] [Crossref]

17. Rajoriya, V., Gupta, R., Vengurlekar, S., Singh, U. S., & Surendra, U. (2024). Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting. International Journal of Pharmaceutics, 655, 123986. [Google Scholar] [Crossref]

18. Hsiao, P. C., Liaw, C. C., & Hwang, S. Y. (2013). Antiproliferative and hypoglycemic cucurbitane-type glycosides from the fruits of Momordica charantia. Journal of Agricultural and Food Chemistry, 61(12), 2979–2986. [Google Scholar] [Crossref]

19. Rajoriya, V., Gupta, R., Rajoriya, V., Chourasiya, S., Patel, K., & Yadav, P. (2026). Precautions in the use of herbal polymers. In S. Jain, R. Gupta, & S. Vengurlekar (Eds.), Applications of herbal excipients and polymers in wound healing (pp. 345–380). IGI Global Scientific Publishing. https://doi.org/10.4018/979-8-3373-3977-1.ch013 [Google Scholar] [Crossref]

20. Shetty, A. K., Kumar, G. S., Sambaiah, K., & Salimath, P. V. (2005). Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin-induced diabetic rats. Plant Foods for Human Nutrition, 60(3), 109–112. [Google Scholar] [Crossref]

21. Ahmed, I., Adeghate, E., Cummings, E., Sharma, A. K., & Singh, J. (2004). Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rats. Molecular and Cellular Biochemistry, 261(1), 63–70. [Google Scholar] [Crossref]

• Artificial Intelligence in Pharmacology, Drug Safety and Toxicity
• Seroprevalence and Associated Risk Factors of Treponema Pallidum Infection among Pregnant Women Attending Antenatal Clinics in Lokoja, Kogi State
• In Silico Evaluation of Hyptis Verticillata-Derived Phytochemicals Targeting Estrogen Receptor Alpha (Erα) and Progesterone Receptor in Hormone-Dependent Breast Cancer
• A Review Article on AI in Personalized Medicine & Novel Pharamacology
• Leech Therapy (Hirudotherapy): A Comprehensive Systematic Review of Pharmacological Constituents, Mechanisms of Action, Therapeutic Applications, and Safety